Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitInvasive candidiasis as a cause of sepsis in the critically ill patientCandida colonization index and subsequent infection in critically ill surgical patients: 20 years laterIntensive care medicine research agenda on invasive fungal infection in critically ill patients.Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells.Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trialThe epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.Fungi are Not All "Fun-Guys" after All.Novel strategies to fight Candida species infection.Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study.Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.Initial therapeutic strategy of invasive candidiasis for intensive care unit patients: a retrospective analysis from the China-SCAN study.Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis.Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasisComparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment.Limitation of (1→3)-β-D-glucan monitoring in major elective surgery involving cardiopulmonary bypass.Treatment of invasive candidiasis in the elderly: a reviewVariation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.The enigma of the major repeat sequence of Candida albicans.Is incidental recovery of yeast from enteric pathogen stool cultures obtained from hospitalized patients clinically significant?Invasive fungal infections in the ICU.Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients.Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU.Current issues in the clinical management of invasive aspergillosis--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.Design and use of Candida scores at the intensive care unit.Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.Candidal thrombophlebitis of central veins: case report and review.Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.Invasive candidiasis: update on current pharmacotherapy options and future perspectives.Invasive fungal infections in the ICU: how to approach, how to treat.Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans.Special Issue: Novel Antifungal Drug Discovery.The impact of real life treatment strategies for Candida peritonitis-A retrospective analysis.Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
P2860
Q21194915-9E0B6B5A-84DC-4992-AAE2-CFEE7C3C0BB4Q22305429-40A0392B-DCA9-4B59-B058-7E4F11DE7F78Q27012454-4A4DB166-239A-4753-A696-918FCA7F28D8Q30235457-09540FA2-D8F0-42A1-A810-689BA4FA5B96Q30658262-63C2FA58-0214-4BAF-976B-573597A66291Q33631387-CD00E29D-C425-4F8E-BD5C-85645FD6FAA4Q33712955-FE2FC53E-4750-458E-B664-F8AB408AA776Q34465297-1717BABA-9DE5-4D21-9458-54BEBB660D12Q34586566-588FA946-2C5A-4CE6-B2A4-C381DC24FA20Q35029633-B918D8D9-D002-4754-8251-2191F14E59B6Q35406737-04C952A6-D242-4D56-91ED-5FE484D83433Q35636971-F4E276C7-09C8-4D0C-BE1A-FF6004F35FEFQ35959489-17803E44-3988-47C8-AC71-631BE01A9577Q36135152-0E7F1E42-7AA3-4ED1-982A-2CBC40DD7AA6Q36257873-3C69CEA3-77A6-46AD-89B3-7387A8C6D2C8Q36434403-4B3711D5-28BF-4E52-9396-5569764F5F30Q36441468-4E03C89E-1E41-4B67-B527-08508755D983Q36571906-D0A0852B-955E-46BF-9FCC-CC525F6C7BAAQ36757660-614C6888-FEFE-4FDE-8033-CE206AB69A95Q36925843-F72666E9-D4B5-422B-8AFB-2F3EFB32427EQ36998720-8D96C6A6-AE2C-4942-BDC7-435B8C176C53Q37170218-20622A66-CCA5-4B19-9128-EDD1FDEF87CEQ37374850-7B2D5F4D-E32B-4659-81B1-9A1E5F5B6FEDQ37405606-7114ED10-2933-434F-95CA-5FB457312939Q37481878-48C05E4C-EB70-4651-8C58-68274AD82A10Q37643057-239AACC2-05E2-4E2D-BFA5-2E7F171F4D34Q37759256-CDD71F2B-3095-4EDD-9218-735B3BE25443Q37867263-151A6AC5-32DE-4C84-8E9F-05EE85049607Q37868705-0072CE84-C0CE-4B02-A760-380C1A23659EQ37871069-B53FE374-A91F-4B3F-8D43-F58B004301A4Q37873554-855175EF-7917-4556-8202-E7B9B81DECE0Q37929789-AC320139-4769-4094-B093-5878606F9C58Q38079194-62E06C72-DAD9-4CD3-B8DC-364302686324Q38110850-CF7A3841-45D8-421F-B035-EC2CB00FD9D7Q38180287-954EBA85-B722-49BB-8568-2316AE33FCAFQ38263282-7388C1B1-DFC2-449E-8EDF-C33CAB49F19DQ38294178-310E256C-DFDE-490D-897D-210F94F8620BQ38774244-66A08EF7-C522-4C62-88F2-0A9AF2399F40Q38859366-814CA687-1A90-4ED7-A195-0235C56274D0Q40066669-6FD31B0B-63A9-4A4F-B51D-BA560D1B086B
P2860
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of invasive candidi ...... I. Epidemiology and diagnosis.
@en
Management of invasive candidi ...... I. Epidemiology and diagnosis.
@nl
type
label
Management of invasive candidi ...... I. Epidemiology and diagnosis.
@en
Management of invasive candidi ...... I. Epidemiology and diagnosis.
@nl
prefLabel
Management of invasive candidi ...... I. Epidemiology and diagnosis.
@en
Management of invasive candidi ...... I. Epidemiology and diagnosis.
@nl
P2093
P921
P1476
Management of invasive candidi ...... I. Epidemiology and diagnosis
@en
P2093
Bart Jan Kullberg
Christian Putensen
Coleman Rotstein
Eckhard Müller
Elie Azoulay
Elizabeth M Johnson
Gabriele Sganga
Georg Auzinger
Mario Venditti
Márcio Borges Sá
P2860
P2888
P356
10.1007/S00134-008-1338-7
P577
2008-10-30T00:00:00Z